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Abstract
Reversibility of state transitions is intensively studied topic in many scientific disciplines over many
years. In cell biology, it plays an important role in epigenetic variation of phenotypes, known as phenotypic
plasticity. More interestingly, the cell state reversibility is probably crucial in the adaptation of population
phenotypic heterogeneity to environmental fluctuations by evolving bet-hedging strategy, which might con-
fer to cancer cells resistance to therapy. In this article, we propose a formalization of the evolution of highly
reversible states in the environments of periodic variability. Two interrelated models of heterogeneous cell
populations are proposed and their behavior is studied. The first model captures selection dynamics of the
cell clones for the respective levels of phenotypic reversibility. The second model focuses on the interplay
between reversibility and drug resistance in the particular case of cancer. Overall, our results show that
the threshold dependencies are emergent features of the investigated model with eventual therapeutic rele-
vance. Presented examples demonstrate importance of taking into account cell to cell heterogeneity within
a system of clones with different reversibility quantified by appropriately chosen genetic and epigenetic
entropy measures.
1 Introduction
Human diseases are typically caused by invading
pathogenic microorganisms, such as viruses, bac-
teria, fungi, prions, etc. Despite immunity sys-
tem is able to cope with the majority of pathogens,
those escaping from innate immunity surveillance
must be treated by therapy. The main obstacle
to efficient therapy is the variability of the mi-
croorganisms within the population, such as strain
or clone, conferring them resistance to therapy.
Population variability flows from the evolutionary
essence of population dynamics of microorganisms
which equips evolving populations of pathogens
with powerful adaptive capability. For example,
evolutionary dynamics of carcinogenesis [1, 2, 3] is
considered the main reason why targeted therapy
does not work [4].
As it is known for a long time, intratumor hetero-
geneity is not bound exclusively to the differences
in DNA sequences of the respective cells (genetic
heterogeneity), but to the epigenetic differences as
well [5]. It is broadly accepted that the epige-
netic mechanisms for gene transcription regulation
are usually reversible [6]. It has been found that
the role of epigenetic mechanisms, such as DNA
methylation, histone modifications, chromatin re-
modeling, and small RNAmolecules, in cancer ini-
tiation and progression is causative [7, 8]. In par-
ticular, variability in phenotypic characteristics of
isogenic cells, known as phenotypic plasticity, is
assumed to be an important cause of the therapeu-
tic resilience of advanced cancers [9].
Recognizing tumor dynamics as evolutionary pro-
cess, one can exploit known universal features of
evolution to influence the evolution of the popula-
tion in desirable direction in mathematically more
purposeful way. While the role of genetic intra-
tumor heterogeneity in tumor evolution was ac-
cepted long time ago, the role of epigenetic hetero-
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geneity is much less obvious. To implement evo-
lutionary principles into the therapy design, the
interplay between genetic diversity and epigenetic
plasticity [10] should be carefully studied at the
model level within an evolutionary-based integra-
tive conceptual framework. Recently, the concept
of Waddington’s epigenetic landscape was applied
to formalize the relation between the cancer cell
genome and epigenetic mechanisms [11] in math-
ematically instructive way. Therein, each point
in the fitness landscape (i. e. genome) provides
epigenetic landscape of unique topology. Due
to their mathematical complexity, the epigenetic
landscapes contain many areas (attractors) around
the stable cell-states corresponding to the respec-
tive stable phenotypes of a cell. Straightforwardly,
the phenotypic switching corresponds to the tran-
sition between two such attractors.
Below we use the above conceptualization [11]
as an instructive backbone for our considerations.
As different cell states in the epigenetic land-
scape differ in their fitness-related properties, the
cell states composition (or non-genetic heterogene-
ity) becomes, from the viewpoint of the clone,
evolutionary important at the clone’s respective
timescale. It was observed that in the case of
variable selective pressure, population of organ-
isms evolve mechanisms to tune the phenotypic
variability to the variability of the acting selective
pressure [12]. In bacteria, the well known risk-
diversification strategy evolved in the populations
when facing uncertain future and/or environment
[13, 14, 15] is the bet-hedging strategy [16, 17, 10].
Based on formal similarity of evolving cancer cells
population with bacteria, viruses or yeast, it has
been recently proposed that the structure of intra-
tumor heterogeneity is evolutionary trait as well,
evolving to maximize clonal fitness at a cancer-
relevant timescale in changing (or uncertain) envi-
ronment and that its structure corresponds to the
bet-hedging strategy [18, 19, 20, 21, 22] which has
been recently put into therapeutic context [23, 24].
To sum up, the genome stays the main protagonist
(i.e. selection unit) in the evolution of cancer cells,
nevertheless with non-genetic heterogeneity of its
eventual clone being the crucial adaptive trait at
cancer-relevant, instead of proximate timescale.
Phenotypic plasticity confers to cellular tissues im-
portant properties, such as the ability of cancer
cells to escape targeted therapy by switching to an
alternative phenotype [25, 26, 27, 28, 29, 30]. It
motivates the effort to stimulate (or prevent) spe-
cific phenotype switching purposefully as a ther-
apeutic strategy [31], which requires deep under-
standing of the phenotype switching causation.
As in classical evolutionary theory are random
mutations, which cause phenotypic variation, in-
dependent of selective pressure, it seems proba-
ble that reversibility of phenotype switching can
be underpinned exclusively by epigenetic modi-
fications. Regarding the therapeutical perspec-
tives, the difference between genetic and epige-
netic changes is fundamental: while the genetic
changes are, in principle, irreversible, the epi-
genetic modifications may be reversible at the
therapy-relevant timescales [26, 32, 33].
To sum up, there are well-founded reasons for
studying phenotypic switching using quasispecies
or population dynamics models, which address the
specific characteristics of cancer. In Section 2 we
present the evolutionary based framework which
assumes environmental dynamics shaping the evo-
lution of reversible switching strategies. In the
quasispecies framework (see Subsections 2.1,2.3,
Appendix A.1) the focus is placed on the pheno-
typic plasticity and reversibility. Studies of qua-
sispecies models yielded important modelisation
ideas about how to implement the immunother-
apy aspects. Most of our efforts in this area have
focused on the construction of the population-
based cancer models where evolution of pheno-
typic reversibility is incorporated together with
immunotherapy. The resulting model of anti-
cancer drug resistance are discussed in Section 3.
In Subsection 3.1 we reassess the problem of in-
tratumoral heterogeneity and related entropymea-
sures. The corresponding simulation results are
provided in Subsection 3.2. The results respond
to specific questions concerning the evolutionary
nature of the drug resistance. The threshold con-
cept has emerged as natural outcome of the simu-
lations. Its importance was underlined by provid-
ing a more detailed supplementary analysis in the
Appendix A.2.
2 Quasispecies model of pheno-
typic changes
In this section we introduce the qualitative time-
continuous evolutionary model based on the sys-
tem of ordinary differential equations. The model
is applied to nonequilibrium scenarios, where con-
strained populations of irreversible phenotypes are
evolutionary drawn towards an attractor popu-
lated by reversible phenotypes.
Recently, mathematical modeling of phenotypic
evolution in variable environment has received sig-
nificant attention [34, 20, 35, 36], which implicitly
addresses the issue of eventual adaptivity of epi-
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genetic modifications [37]. In particular, the for-
mulation based on the quasispecies model [38] has
been developed to clarify the role of mutations in
the evolutionary process [39, 40, 41, 42]. Owing to
its versatility, the model has found applications in
a broad range of scales - from molecular and virus
scales [43] up to the cellular systems, such as the
populations of heterogeneous cancer cells [44, 45].
Investigation of heterogeneous malignant tissues
within the context of variable environments [46]
including local anticancer drug-induced environ-
ments [47] emerges as an interesting research area.
The entropic variable constraints imposed on the
heterogeneity were studied in [48]. In [49], the
elimination of heterogeneity in the system of repli-
cating entities was conceived as an inverse prob-
lem, with an eventual potential in therapeutical
applications.
Before going into details, we highlight three salient
features of the model: (i) periodicity of the (mi-
cro)environmental variations; (ii) substantial ge-
netic diversity underlying the switching rates be-
tween isogenic phenotypes (phenotypic states);
(iii) competition between the clones adopting ei-
ther reversible or irreversible phenotype switching
under the constraint of constant total cell popula-
tion size.
Below we study effects of the variation of evolu-
tionary rate on the fractions c(z)(k, t), k = 0,1, . . . ,
ns − 1, of ns clones (abstract ”genotypes”), each
of them allowed to occupy one of the two phe-
notypic states, indexed by z ∈ {0,1}. We assume
that the k-th genotype responds to the environ-
mental variation in two alternative ways depend-
ing on its respective phenotypic state, [k;z = 0] or
[k;z = 1]. The time-variability of environment can
be indirectly represented by the time-variability of
the reproduction rates of the respective phenotypic
states, r(z)(t), z ∈ {0,1}, which are supposed to be of
harmonic periodic form
r(z)(t) = rB + (−1)
z
∆r cos(2pit/T ) (2.1)
defined by the period T ; ∆r corresponds to the de-
gree of diversification of the reproduction fitness
and rB to its basal level. It is worthy of noting
that in [50] the oscillatory external (temperature)
conditions are used to drive the evolution of the
class of interacting information-carrying molecu-
lar replicators with the capability of reversible in-
termodal switches.
Presuming that the replication dynamics is re-
stricted to the concentration plane c(0)(k, t) ≃
c(1)(k, t), the parameter rB ≃ [r
(0)(t) + r(1)(t) ]/2 may
be interpreted as static effective replication rate.
Many natural cycles may imply changes in the
replication rate, which can be, within the con-
text of cancer research, exemplified by the cyclic
hypoxia-reoxygenation exposure within solid tu-
mors [51].
To study quasispecies dynamics with purposefully
specified the reversibility between the phenotypes
z = 0 and z = 1 in the respective clones, we define
the parameter ϕ ∈ 〈0,1〉, via the linear relation
ϕ(k,ns) =
ns − k − 1
ns − 2
, k = 1, . . . ,ns − 1 , (2.2)
which uniformly discretizes commitment of the cell
to the respective phenotype. The labeling of the
clones by the index k is introduced to make next
formalization more feasible. Among the possible
states we highlight the neutral (or ”symmetric”)
case ϕ(ns/2,ns) = 1/2 (equal commitment to ei-
ther phenotype), as well as the ”boundary” cases
ϕ(1,ns ) = 1 and ϕ(ns − 1,ns) = 0 corresponding
to exclusive commitment to the respective pheno-
type, which implies complete irreversibility. In
the following, the range of indices k is completed
with k = 0 which represents the wild clone (nei-
ther mutations nor transitions between pheno-
types are applied). Let (1 − ϕ(k,ns))c
(1)(k, t) and
ϕ(k,ns)c
(0)(k, t) specify intensity of the transitions
from the phenotype 0 to the phenotype 1, and vice
versa. The above terms can be combined to de-
scribe the switching flow
Jsw(k,ns , t) = (1−ϕ(k,ns))c
(1)(k, t) (2.3)
− ϕ(k,ns)c
(0)(k, t) ,
which, when incorporated into dynamics, changes
phenotypic fractions corresponding to z = 0 and
z = 1 in each of the respective clones k =
1,2, . . . ,ns − 1. In further, the direction of the
switching flow (−1)zJsw is controlled by the pref-
actor (−1)z . Assuming non-negativity of the frac-
tions, irreversibility of the ”boundary” species is
consistent with unidirectionality of the ”bound-
ary” flows Jsw(1,ns , t) = −c
(0)(1, t) ≤ 0 and Jsw(ns −
1,ns , t) = c
(1)(ns − 1, t) ≥ 0. This sharply con-
trasts with the central species kcentral = ns/2,
where ϕ(kcentral,ns) = 1/2 provides Jsw(ns/2, t) =
(1/2)[c(1)(ns/2, t) −c
(0)(ns/2, t)] which reflects the
fact that both directions of the flow (i.e. Jsw ≥ 0,
Jsw ≤ 0) are allowed for c
(z)(ns/2, t). As Jsw(k,ns , t)
is constructed without considering explicit causal
sensoric response [52], it can be viewed as
a population-level consequence of evolved bet-
hedging strategy within the context of quasispecies
ODE (ordinary differential equations). Note that
the structure of switching term on the population
level is similar to that used to describe the dichoto-
mous switching of tumor cells [53]. Specific terms
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of this type related to the transitions between bac-
terial subpopulations were applied as well [54].
We postulate that the initial population is formed
exclusively by the zero-th clone, which is gradually
redistributed (by mutation mechanisms) among
the concurrent clones, k = 1,2 . . . ns − 1. If the phe-
notype switching absents for k = 0, the dynamics
of the population, c(z)(0, t), follows
dc(z)(0, t)
dt
= [r(z)(t)−Φ(t) (2.4)
− (ns − 1)µ ]c
(z)(0, t)
and the population fraction k = 0 changes exclu-
sively due to irreversible mutations. Their impact
is modeled by −(ns−1)µc
(z)(0, t) terms proportional
to the positive coefficient µ. The additional as-
sumption is, that all mutants k = 1,2, . . . ,ns − 1 are
produced with the same rate µc(z)(0, t). The compe-
tition controls proliferation via the scalarΦ(t) term
which is interpreted later. The Eq.(2.4) is consid-
ered together with the ODE system
dc(z)(k, t)
dt
=
[
r(z)(t)−Φ(t)
]
c(z)(k, t) (2.5)
+ µc(z)(0, t) +m(−1)zJsw(k, t)
written for k = 1,2, . . . ,ns − 1, constructed to de-
scribe combined effect of the replication, selection
and switching.
The newly introduced parameterm controls the in-
tensity of the phenotype switching and can be in-
terpreted as the measure of reversibility. The limit
conditions under which the effect of mJsw is signif-
icantly weakened can be viewed as conditions sup-
porting conservative bet-hedging [21]. For the sake
of simplicity as well as better understanding of the
model implications, the parameter m is chosen to
be uniform over the clones.
Regarding the structure, description and inter-
pretation of the switching process at the level
of ODE, we note that: (i) it follows from the
Eq.(2.5) that the total rate of the clonal fractions
d(c(0)(k, t) + c(1)(k, t))/dt loses explicit dependence
on Jsw(k, t); (ii) without mutation and replication
terms the particular phenotypic equilibria can be
formed when [Jsw(k)]equil
!
= 0, which leads to the
ratio [c(1)(k)/c(0)(k)]equil = ϕ(k,ns)/[1−ϕ(k,ns)]. The
competition among the clones is described conve-
niently using constraint of constant overall popu-
lation density
c
(0)
Σ
(t) + c
(1)
Σ
(t) = 1 (2.6)
with the particular terms
c
(z)
Σ
(t) =
ns−1∑
k=0
c(z)(k, t) , z = 0,1 . (2.7)
If the sum of the left and right hand sides of
Eq.(2.4) and Eq.(2.5) is carried out, and the result
is compared with Eq.(2.6), the scalar correction to
the reproduction rate may be constructed as
Φ(t) =
∑
z=0,1
r(z)(t)c
(z)
Σ
(t) . (2.8)
In order to reduce the initial asymmetry, we have
used in our simulations (see Subsection 2.3 in be-
low) of quasispecies model the initial conditions
c(z)(k, t = 0) =
δk,0
2
, z ∈ {0,1} , (2.9)
where δk,0 is the Kronecker delta. It means, that in
the case of the initial demise of the k = 0 species,
we expect the repopulation towards the species
k = 1,2, . . . ,ns − 1. Since the mutations contribute
uniformly to the expansion of all remaining clones
(k , 0) with the same rate µc(z)(0, t), the decisive
contribution to the disparity of the fractions is ex-
pected solely from the switchingmechanismwhere
diversification is guaranteed by the use of ϕ(k,ns).
2.1 Entropy measures
of heterogeneity
The general concept of entropy is used in vari-
ous scientific fields and can therefore be perceived
differently according to the purposes of the infor-
mation processing in the respective areas of bio-
logical research. Shannon entropy is an example
of the key systemic measure designed to quantify
the information storage, transfer or system hetero-
geneity/diversity. One key step in this direction is
the idea to join a fitness concept to information-
based characteristics by the value of information
[55]. According to [56], the entropy-based mea-
sure can be used as a predictive indicator of the
evolutionary efficiency in avoiding extinction. The
measures can quantify diversity within the context
of phenotypic switching [57] analogously as in pre-
sented work. In the field of cancer biology and di-
agnostics, biostatistics, as well as in the studies of
cellular composition, the entropy can be utilized to
monitor and characterize dynamics of heterogene-
ity at many levels. Shannon entropy is currently
considered the most promising robust metrics and
the tumor-specific imaging biomarker to enable ra-
tional prognostic analysis based on the data gath-
ered from CT-scans [58].
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In our specific context, to characterize selection
strength and asymptotic behavior at the systemic
level, we focus on the measures of heterogeneity of
evolving population fractions. To quantify the dy-
namic heterogeneity we utilize two different mea-
sures. The first of them is Shannon entropy
SEPIG(t) = −
∑
z=0,1
ns−1∑
k=0
c(z)(k, t) lnc(z)(k, t) , (2.10)
which reflects the epigenetic information. It is ob-
vious, that this form is sensitive to the arrangement
of phenotypic fractions. On the contrary, the intro-
duction of measures based on the total concentra-
tion
c(k, t) = c(0)(k, t) + c(1)(k, t) (2.11)
or another meaningful algebraic combinations of
c(0), c(1) is a way how to abandon phenotypic de-
tails (including subtle oscillations). Therefore, the
genetic heterogeneity and variability can be better
described by
SG(t) = −
ns−1∑
k=0
c(k, t) ln(c(k, t)) . (2.12)
Both SEPIG and SG measures can be constructed
regarding often used analogy between probability
and occupancy fraction [49].
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Figure 2.1: Panel (A): Schematic diagram of the quasispecies model (ns = 6) introduced in Section 2. Special
emphasis is placed on the reversibility imposed by ϕ. Panel (B): The time dependence of ns = 6 species frac-
tions in periodic environment (T = 10). The calculations have been performed for the parameters ∆r = 0.4,
µ = 0.01, m = 0.05. The highest (effective) replication rate observed for the highest reversibility correspond-
ing to ϕ(3,ns ) = 1/2. The fractions of the other species are suppressed in the long run (limit cycle regime).
2.2 Effective replication rate
of the clone
To investigate the behavior of the system of equa-
tions (2.4) and (2.5) we proposed an alternative ef-
fective description. Within this, the effective dy-
namics of total fraction c(k, t) (see Eq.(2.11)) can be
expressed by simple formula
dc(k, t)
dt
= (ref f (k, t)−Φ(t))c(k, t) . (2.13)
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Figure 2.2: Panel (A) shows the time dependence of the entropy measure SEPIG (the inset includes com-
parison with SG). The difference between the sub-threshold (∆r = 0, absence of the variation) and super-
threshold fitness environmental variations (alternatives ∆r = 0.2, 0.4). Calculated for the period T = 10.
Remaining undetermined parameters are µ = 0.01 and m = 0.05. In the panels (B) and (C) we plot the time
dependencies of the effective index kmax(t) + zmax(t) × 0.3. Here symbol max is related to the species of the
maximal abundance and the auxiliary constant 0.3 is chosen for the visualization purposes only. For example
in the case zmax = 0 the plot hits the mesh line [see c
(0)(5), c(0)(4), c(0)(3), c(0)(0) in the panel (C)] correspond-
ing to the species of the maximal instant concentration showing the enhanced selection for the phenotype
with highest reversibility, i.e. for ϕ = 1/2, ϕ/(1−ϕ) = 1. In panel (B), the evolution in the static environment
remains frozen at kmax = 1, zmax = 1, whereas the evolution obtained for ∆r = 0.2 in panel (C) asymptoti-
cally supports the selection for the phenotype with highest degree of reversibility kmax = 3, zmax = 0, 1 and
ϕ(3) = 1/2. (The results obtained for higher ∆r are qualitatively similar.) Panels (D), (E), (F) depict effects of
the number of clones ns ∈ {12,24,48} and ∆r ∈ {0.2,0.4,0.6} on the SEPIG(t).
Here, the effective replication rate of the k−th clone
ref f (k, t) plays a key role for many results to follow.
The phenomenology avoids the formal use of mu-
tations, switching or c(0)(k, t), c(1)(k, t). The summa-
tion of the equations Eq.(2.13) leads to the formula
Φ(t) =
ns−1∑
k=0
ref f (k, t) , (2.14)
which implies the interpretation of Φ as a to-
tal replication rate. Moreover, the consistence of
Eq.(2.14) and Eq.(2.8) can be accomplished for the
”mixed-type” solution (see also [36])
ref f (k, t) = r
(0)(t)c(0)(k, t) + r(1)(t)c(1)(k, t) . (2.15)
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Figure 2.3: The differences in the efficiency of selecting extreme reversibility within the frame of nonequilib-
rium evolutionary dynamics. The panels show dependencies of the entropy measure SEPIG(t = th) calculated
for various combinations of parameters and time horizons th ∈ {1000,2000,3000}. Panel (A) involves the
threshold dependencies on the mutation rate µ. Note that sufficiently large µ is needed to overcome the
initial barrier of forming heterogeneous state from which selection can be realized. According to panel (B)
the more intense environmental changes, the faster selection for the most reversible clone. Panels (C), (D)
indicate non-monotonous dependence on T . In case (D), obtained for ∆r ∈ {0.1,0.2,0.4}, the efficiency of
selection reduces for the wide range of T until global minima T ∼ (25−90) are attained. Obviously, as shown
in panels (E), (F), selection mechanism can be easily accelerated by increasing the switching rate parameter
m.
2.3 Numerical investigation
Apart from a few numerical exceptions, listed ex-
plicitly in the figure captions, the simulations have
been performed for ns = 6 species and the param-
eters T = 10, rB = 1, ∆r ∈ {0.1,0.2,0.4}, m = 0.05,
µ = 0.01. In agreement with intuitively expected
behavior of the model, Fig. 2.1 shows gradual qual-
itative progress in the redistribution of the species
fractions. At the intermediate time scales (10a.u.−
100a.u.), there is a period of ”hesitancy”, where all
the clones k > 1 nearly counterbalance their respec-
tive competitors. During this short initial phase,
the variable environment causes that the putative
equality among the clones k = 1,2, . . . ,6 gradu-
ally vanishes and the highest reversibility due to
ϕ = 1/2 corresponding to the ratio ϕ/(1 − ϕ) = 1
attributed to the clone kcentral = ns/2 = 3, leads at
the long run (≥ 1000) to the largest ref f [see the
analytical approximation given by Eq.(A.10) in the
Appendix A.1].
Fig.2.2 shows the non-trivial transient states and
the initial increase common for SEPIG and SG. The
largest differences between SEPIG and SG are local-
ized mainly in the long-time asymptotics. Here,
the main question arises to what extent environ-
mental variability affects the long-term hetero-
geneity of the populations. There are many indi-
cia that populations obtained for large and small
∆r significantly differ. Fig.2.2 depicts both the
entropy measures as functions of ∆r, which is
the main determinant of environmental variability.
The variability causes the convergence of SEPIG to
the positive limit value, while trivial limit SG → 0
indicates dominance of the single species. For
small ∆r, there are only very low evolutionary ben-
efits due to switching between phenotypic states,
which leads to extremely slow evolution. This
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means that numerical approach becomes inappro-
priate to capture the subtle differences between
non-equilibrium decay and long-time limit cycle
behavior.
The numerical problems stimulated development
of analytical approximation discussed in Appendix
A.1. Both approaches are consistent in indicat-
ing of the fact that convergence to the most re-
versible clone is faster as ∆r increases [see panel
(C) of Fig.2.2 ]. In addition, it appears that for
given time horizon th the increase in ∆r leads to the
threshold-like behavior [see Fig.2.3 (B)]. Accord-
ing to Fig.2.2 (B), without sufficient environmental
variability most of the population remains trapped
in the clone k = 1. Fig.2.3 summarizes the entropic
responses induced by µ, ∆r, T and m. For exam-
ple, panels (C) and (D) show how the choice of T
affects the efficiency of the selection of the most re-
versible strategy. It turns out that large enough T
supports rapid selection. In agreement with the in-
tuitive expectations, the process can be reinforced
by super-threshold value of m.
↓ µ ↓ µ ↓ µ CP { mutations
C
(0)
L0 C
(0)
L1 C
(0)
H
ր αH
∣∣∣ xp αL ∣∣∣ 1/xp αH ∣∣∣ xp drug
efficiency
∣∣∣ specificity
CP −→ 6µ ϕL l m ϕL l m 1/2 l m commitment
∣∣∣ reversibility
ց αL
∣∣∣ 1/xp αH ∣∣∣ xp αL ∣∣∣ 1/xp drug
efficiency
∣∣∣ specificity
C
(1)
L0 C
(1)
L1 C
(1)
H
↑ µ ↑ µ ↑ µ CP { mutations
Table 2.1: The scheme depicts the relations between abundances CP , C
(z)
L0 , C
(z)
L1 , C
(z)
H ; z ∈ {0,1} mutation
(∼ µ) and switching (∼ m) processes; the variants of phenotypic state commitments {ϕL, 1/2} [see Eq.(3.5)],
drug efficiencies {αL, αH , 1} [see Eq.(3.7)], and drug specificities {xp, 1/xp} [see Eq.(3.8)] within the model
represented by Eq.(3.9).
3 Model of immunotherapy
In the next we apply the above framework to
investigate evolutionary aspects of the resistance
to immunotherapeutic drugs caused by pheno-
typic reversibility. We built the new model
using the exogenous simplified variant of the
Kirschner-Panetta (KP) model of immunotherapy
[59]. The original KP model consists of the three
autonomous equations, for the effector cells pro-
duction, tumor growth with tumor clearance, and,
finally, equation for cytokine interleukin-2 (IL-2)
production. Essential in the original KP model is
the boosting of the IL-2 against tumors. There are
many versions of the model that include simplified
but biologically plausible approaches [60]. In [61]
the gene therapy characterized by populations of
effector and cancer cells was described by means
of two coupled autonomous ODE. Recently, two-
populations cancer model [62] with competitive
interaction has been used to investigate the com-
bination of immunotherapy and chemotherapy.
Here, we present a simplified model of a single
cancer clone where a population of cancer cells
varies accordingly to exogenous ODE
dC
dt
= rC(1−C)− a
e(t)C
C + g
. (3.1)
Consistently with the original KP model, the ef-
ficiency of therapeutic interventions is described
by the clearance parameter a. The parameter g
plays the role analogous to that in the Michaelis-
Menten kinetics. Regarding the treatment classifi-
cation based on the rate of tumor cells killing, the
model term −ae(t)C/(C + g) corresponds to the cy-
totoxic activity of non-logkill type [63]. Unlike the
quasispecies model, the rate of replication r does
not change. The classical logistic term rC(1 − C)
is used for the nutrient-limited cancer growth of
the rescaled abundance of tumoral cells C. Its use
[loosely analogous to Φ from Eq.(2.14)] causes that
tumor size stabilizes at C ≤ 1. (The carrying capac-
ity is equal to 1 in here adopted scaling).
Dynamics of environment is mediated by the pop-
ulation of the effector cells. We assume that popu-
lation size e(t) varies according formula
e(t) = eB +∆e cos
(
2pit
T
)
. (3.2)
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This simplification exploits a few aspects: (i) the
exogenous formulation is parametrically less de-
manding than the original autonomous (endoge-
nous) KP model; (ii) it can be easily linked to the
harmonic model of replication rate r(z)(t) proposed
in Eq.(2.1) with the exception that it cancels the de-
pendence on z ∈ {0,1} (the phenotypic state depen-
dence is restored in the Subsection 3.1 by introduc-
ing additional parameters to represent therapeu-
tic interventions); (iii) it avoids the ODE stiffness
problems typical of the original KP formulation;
(iv) the harmonic character of Eq.(3.2) is qualita-
tively consistent with KP phase diagrams [59] be-
longing to the dynamical regimes with some limit
cycle attractors; (v) periodicity is consistent with
the therapeutic option for immuno-oncological dy-
namics [64].
Before studying more complex numerical exam-
ples, we continue with the parametrization of the
elementary model based on Eq.(3.1) and Eq.(3.2).
According to the results, the system preliminary
simulated with the initial condition C(0) = 0.1 for
ten periods exhibits the largest susceptibility to the
changes in g for the parameters
eB = 0.5 , ∆e = 0.4 (analogs of rB and ∆r) ,
g = 0.45 , a = 1 , T = 10 , r = 1 (fixed) .
(3.3)
The parameters are intended for further simula-
tions of multiclonal populations of cancer cells.
3.1 Diversification of the effects of im-
munotherapy
To illustrate the role of reversibility of pheno-
typic switching in the evolution of the therapy
resistance, we construct the evolutionary model
where reversibility is considered along with in-
tratumor heterogeneity reflected by the clone-
dependent and state-specific sensitivity to drug. It
works with the population of seven rescaled in-
stant species abundances, forming the set setE(t) ≡
{CP(t), C
(0)
L0 (t), C
(1)
L0 (t),C
(0)
L1 (t),C
(1)
L1 (t), C
(0)
H (t), C
(1)
H (t)},
where CP(t) denotes the abundance of the primary
cancer cells.
Four abundances C
(z)
L0 (t), C
(z)
L1 , z ∈ {0,1} correspond
to two clones L0,L1 with low reversibility (indexed
as L) between states. The clones are characterized
by the commitment ϕL ∈ (0,1/2〉. Here, the a priori
tendency toward low reversibility (with the obvi-
ous exception for ϕL = 1/2) is ensured by the com-
bination of ”asymmetric” commitments ϕL, 1 −ϕL
(which occur in the complementary pairs of the
switching flows). The supplementary lower nu-
merical index 0 in C
(z)
L0 (or 1, respectively) indicates
that immunotherapy is specially designed to have
more profound impact on the phenotypic state 0
(or 1) (therapeutic effectiveness is below denoted
as αH ), whereas the alternate phenotypic state is
eliminated with lower efficiency (αL, see below).
The commitment equal to 1/2 (high reversibility) is
imposed on the cloneH characterized by the abun-
dances C
(0)
H , C
(1)
H .
The overview of the theoretical structure of the
model is schematically highlighted in Table 2.1. In
contrast to the quasispecies model, the sum
CΣ ≡ CP +
∑
z=0,1
(
C
(z)
L0 +C
(z)
L1 +C
(z)
H
)
(3.4)
is not normalized to unity but, instead, (1 − CΣ)
is used to construct the logistic form rC(1 − CΣ)
which guarantees CΣ(t) ≤ 1 for proper initial con-
ditions. Similar term that sets upper limit on the
abundance of the mixed populations can be found
elsewhere [65, 66, 62].
As we pay attention to the problem of reversibility
within the context of heterogeneity, the switching
flows within the clones L0, L1, and H are defined
as it follows
JswL0 = (1−ϕL)C
(1)
L0 −ϕLC
(0)
L0 , (3.5)
JswL1 = (1−ϕL)C
(1)
L1 −ϕLC
(0)
L1 ,
JswH =
1
2
(
C
(1)
H −C
(0)
H
)
.
All population rates are defined by the universal
formula consisting of the adaptations of Eq.(3.1)
and former variant of the switching flow model
R(C˜, J˜ , α˜,Nµ) = rC˜(1−CΣ)
(3.6)
+mJ˜ − α˜a
e(t)C˜
CΣ + g
+Nµ µCP ,
where C˜, J˜ , α˜,Nµ are some auxiliary general
variables which are substituted by some spe-
cific variables and constants: C˜ ∈ setE, J˜ ∈
{ JswL0, JswL1, JswH }, α˜ = {αL,αH }, Nµ ∈ {−6, +1}. In
comparison with Eq.(3.1), we also include muta-
tion mechanism (∼ NµµCP ) and switching (∼ mJ˜)
already used in the quasispecies simulations.
The contributions related to the switching pro-
cess are adopted from [53]. The alternatives JswL0,
JswL1, JswH (might loosely correspond to ”escape
routes” for the respective cancer sub-populations
[25]. Conversions between drug-resistant and
drug-sensitive clones are the main issue of the re-
sulting construction considered in line with the ab-
stract model [67] used as a prototype. To study
bacterial persistence under conditions of antibi-
otic stress, a similar, two-component population
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model was proposed in [68]. Finally, the techni-
cal details of simultaneous incorporation of muta-
tions and the switching processes into the model of
epigenetically structured population can be found
elsewhere [69].
To introduce the clone- and state-dependent sen-
sitivity to drug into the model, the scalar clear-
ance parameter a in Eq. (3.1) is in Eq.(3.6) replaced
by the species-dependent term α
(z)
j a, j ∈ {0,1}, z ∈
{0,1} with the prefactor representing a modifier of
the drug efficiency of the phenotype z of the clone
j . To stay consistent with the formal structure of
the model, α
(z)
j is represented by four matrix el-
ements, α
(0)
0 ,α
(1)
0 ,α
(0)
1 ,α
(1)
1 , related to the particu-
lar clone and phenotype. Nevertheless, to keep the
conceptual model instructive, we assume only two
basic levels in the matrix elements, one for diago-
nal, one for non-diagonal elements, respectively α(0)0 α(0)1
α
(1)
0 α
(1)
1
 =
(
αH αL
αL αH
)
. (3.7)
We note that diversity of the forms ofR condition-
ing diversity within setE stays sufficient as it is not
based explicitly on the effect of α˜ ∈ {αL,αH }, but on
the possible combinations of α˜ with the commit-
ment terms ϕL,1 − ϕL,
1
2 coming from JswL0, JswL1
and JH as well.
Both αL, αH , representing low/high therapeutic ef-
fects, respectively, can be further parametrized by
the single auxiliary parameter xp ≥ 1
αH (xp) = xp , αL(xp) =
1
xp
. (3.8)
The parametrization is designed to satisfy require-
ments α
(z)
0 α
(z)
1 = αL(xp)αH (xp) = 1 and 0 < αL ≤
1 ≤ αH for both phenotypic states z ∈ {0,1}. In
the special boundary case xp = 1 which implies
αL(1) = αH (1) = 1, there is no modification of a.
To sum up, the parameter xp can be interpreted as
a measure of specificity of immunotherapeutic inter-
vention. To present a microscopic view of the prob-
lem studied, we outline an interpretation in which
xp integrates the basic mechanisms, such as the
specific efficacy of the tumor-associated antigens,
the ability of tumors to activate T-cell responses in-
cluding the tumor recognition and the induction of
cancer cell deaths [70].
By combining Eq.(3.5) with Eq.(3.6), the popula-
tion dynamics of (1 + 6) tumor species can be ex-
pressed as it follows
dCP
dt
= R(CP ,0,1,−6) , (3.9)
dC
(z)
L0
dt
= R(C
(z)
L0 , (−1)
zJswL0,α
(z)
0 ,+1) ,
dC
(z)
L1
dt
= R(C
(z)
L1 , (−1)
zJswL1,α
(z)
1 ,+1) ,
dC
(z)
H
dt
= R(C
(z)
H , (−1)
zJswH ,α
(z)
0 ,+1) .
The first formula of the list expresses that pheno-
type switching absents (zero at the second position
of R) in the primary tumor clone. This choice is
consistent with the quasispecies model. In addi-
tion, there is no modification of the drug sensitiv-
ity a (α˜ = 1). The factor (−6) expresses that muta-
tion process modifies the primary tumor growth by
subtracting rate factor 6µCP . We assume that the
”most reversible” and ”symmetric” transitions be-
tween phenotypes corresponding to C
(0)
H and C
(1)
H
are violated by the factor α
(z)
0 , 1.
As in the case of quasispecies model, now we pro-
pose measures that allow better interpretation of
the results. Again, the appropriate transformations
allow us to define proper measures of heterogene-
ity. For all CE ∈ setE the rescaling (CE /CΣ) can be
performed, that guarantees
∑
CE∈setE
(CE /CΣ) = 1.
In this case, the tumor can be monitored by epi-
genetic entropy-like measure
SCEPIG = −
∑
CE∈setE
CE
CΣ
ln
CE
CΣ
. (3.10)
In analogy with Eq.(2.11), we define four-element
auxiliary set setG ≡ {CP , C
(0)
L0 + C
(1)
L0 , C
(0)
L1 + C
(1)
L1 ,
C
(0)
H +C
(1)
H } which allows modification of the origi-
nal definition of Eq.(2.12) to the form
SCG = −
∑
CG∈setG
CG
CΣ
ln
CG
CΣ
. (3.11)
3.2 Simulation results - evolution of
the therapeutic resistance
The results of numerical simulations are depicted
in Fig.3.1 and Fig.3.2. They are obtained for the
initial conditions
CP(0) = CP0 , (3.12)
C
(z)
L0 (0) = C
(z)
L1 (0) = C
(z)
H (0) = 0 , z ∈ {0,1} .
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Figure 3.1: The numerical results obtained for the model incorporating evolution of reversibility and resis-
tance to immunotherapy. In addition to other parameters we kept µ = 0.01, m = 0.05 and xp , ϕL, th specified
in the panels. The tumor is variable in size (CΣ(t)) and phenotypic structure ( CE ∈ setE). Panels (A), (B) show
some differences in the course of the tumor progression (xp = 1.16, ”rapid progression”; xp = 1.14, ”slower”
progression; xp = 1.11, ”shrinking”) for three selected values of xp characterizing qualitative differences in
the therapeutic effects on the phenotypic states; (e.g. drug specificity xp = 1.11 implies αL ≃ 0.9009); Panel
(B) shows specific phenotypic dynamics. It shows that despite the high reversibility [commitment 1/2 incor-
porated into JswH in the case of clone [H ;z ∈ {0,1}]], the abundance C
(1)
H (t) drops at the late times as a result of
the loss of the ability to compete. Panels (C), (D), . . . (G), (H) reveal details of xp influence calculated for two
time horizons th ∈ {100, 500} . The threshold between slow and rapid tumor progression can be identified.
The threshold character is confirmed by the fact, that the transitions due to xp are getting sharper as the th
increases. The sharpening due to a change in th from th = 100 to th = 500 is also noticeable for the panels (G),
(H), where more detailed information on the population structure is available. The panels (E), (F) depict the
formation of the threshold values in the Shannon entropies as heterogeneity measures. Panels (G), (H) show
that C
(0)
L1 dominates over a wide range of xp although the corresponding ϕL = 0.25 is quite far from the ideal
reversibility corresponding to 1/2. From panel (H) we see that the significant long-term desirable effect of
therapy persists only in the case of C
(0)
L0 and partly in the case of C
(1)
L0 .
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Figure 3.2: The evolutionary dynamics reflected by the heterogeneity measures SCG (t) and S
C
EPIG(t). The
numerical results obtained for the additional parameters µ = 0.01, m = 0.05 and xp ,ϕL listed on the top
of figure panels. The scenarios corresponding to different xp are qualitatively similar: the initial increase
associated with a large number of possibilities is replaced in the peak zones by the favorable growth of
selected clones, i.e. clonal expansion. A weakened preference due to xp = 1 in panel (A) leads to the highest
entropy among the considered outcomes. Panels (B), (C) show the transition stages. Panel (D) indicates
that differences between epigenetic and genetic entropy measures are almost entirely neutralized if selective
pressures due to immunotherapy are strong enough. For (B), (C), (D) panels the after peak behavior of SCG (t)
changes smoothly contrary to ”jagged” form of SCEPIG(t).
In the following calculations the parametric value
CP0 = 0.001 and parameters defined by Eq.(3.3)
from the Section 3 are used, with the exception of
xp and ϕL, which are listed in the respective figure
captions. The applied initial conditions resemble
those considered in the work [47].
As is clear from the respective panels of Fig.3.1,
the different combinations of the drug specificity
parameter xp and phenotypic commitment param-
eter ϕL ∈ {0.25,0.37,0.5} trigger different competi-
tive behaviors, which are manifested for different
time horizons th ∈ {100, 500 }.
A more detailed look in the panels (A), (B) of
Fig.3.1 which show the monitoring of CΣ and C
(1)
H
reveals additional systemic features. For such char-
acteristics, quite strong preference defined by xp =
1.16 implies very rapid growth, with as few as 200
time units nearly sufficient to achieve carrying ca-
pacity. Although the abundance CΣ stabilizes at
its upper limit, there are still internal changes in
the clonal subpopulations which are visible in vari-
ations of C
(1)
H . The competition under saturated
conditions leads to the loss of C
(1)
H dominance, giv-
ing advantage to other clones. Owing to locating
simulation intentionally in the area with a rela-
tively high sensitivity to xp , even a small reduction
to xp = 1.14 makes anticancer effect more appar-
ent. In such case, 300 time units are necessary to
attain saturation. This slowing down of the pro-
gression relates to the fact that more distributed
therapy weakens not only dominant but, at least
partially, other phenotypic variants as well. The
dynamics presented in the panels (A), (B) enabled
us to focus on the appropriate time horizons t = th
for which, consequently, dependence of the respec-
tive values CΣ(t = th) on xp was calculated. As the
panels (C), (D) show, larger th leads to more pro-
nounced transition in CΣ. The entropy dependen-
cies depicted in panels (E), (F) confirm the global
trend which can be attributed to the enhanced se-
lection due to higher xp . We note, that this re-
sult was achieved presuming that all tumor clones
are well identifiable which, however, contradicts to
currently known limitations of biopsy and histol-
ogy [71].
However, the slight global decrease in xp is not
the only remarkable trend of the entropy as, apart
from it, the local modulation caused by the pres-
ence of the threshold is present as well. For a more
comprehensive understanding of the entropic dy-
namics, Fig.3.2 is presented, since projection of en-
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tropy values extracted exclusively for t = th is not
very illustrative Besides the plots of SCG (t = th) and
SCEPIG(t = th), Fig.3.2 highlights the fact that en-
tropy scenarios are universal owing to their simi-
larity with those depicted in Fig.2.2.
Interestingly, regarding the time dependencies
SCG (t) and S
C
EPIG(t), both models, the quasispecies
as well as the cancer population model, reveal
many common and universal features, such as
the overall single-peaked shape, direct proportions
SEPIG ∼ SG and undulating S
C
EPIG(t), which con-
trasts with much smoother SCG (t). In addition,
the findings imply that the amount of informa-
tion/heterogeneity expressed by SCEPIG exceeds S
C
G ,
which is consistent with the assumption of the ad-
ditional epigenetic information [7], which warns
that a ”summative” framework [here represented
by Eq.(3.11)] can overlook certain short-term de-
tails of the phenotypic population structure. Sim-
ilarly as in the case of quasispecies model, the
threshold effect emerges. In this case, its impor-
tance derives from its relevance to the therapeu-
tic efficiency since the threshold separates growth
regime from the regime of the slow growth or de-
cay dynamics. Further details related to the inves-
tigation of the threshold sensitivity to the phase
differences of the environment as well as supple-
mentary algebraic characteristics derived for ODE
system Eq.(3.9) are listed in the Appendix A.2.
Fig.3.1(H) displays the formation of the asymptotic
regime in the region above the threshold. As one
can see, the following ascending ordering of the
abundances stabilizes at long times (th ≥ 500):
C
(0)
L0 < C
(1)
L0 < C
(0)
H < C
(1)
H < C
(1)
L1 < C
(0)
L1 . (3.13)
The ordering at the level of the pairs C
(0)
L0 < C
(1)
L0 ,
C
(0)
H < C
(1)
H , C
(1)
L1 < C
(0)
L1 is the consequence of im-
posed immunotherapeutic effects represented by
αL < αH involved in Eq.(3.6). Although design of
JswH is originally motivated to demonstrate supe-
riority of reversible clones in the variable environ-
ments, our results show that pathway to drug re-
sistance is not necessarily associated with the se-
lective advantage of the clone H (with the struc-
ture [H ;z ∈ {0,1}]). The situation, in which the
abundances corresponding to L1 exceed those of
H (which are more populated than L0) is implied
by the role of ϕL and αH (or αL) in variable envi-
ronment. A qualitative explanation has origin in
the structure of JswL0 [see Eq.(3.5)]. According to
it, the choice ϕL ≤ 1/2 favors the phenotypic state
[L0;z = 0] compared to [L0;z = 1]. Similarly, due to
net effect ofϕL, the structure of JswL1 suggests com-
mitment to [L1; z = 0] thereby providing higher fit-
ness than [L1; z = 1]. But the immunotherapeutic
effect of α
(0)
0 = αH is strong enough to cause a sig-
nificant reduction of C
(0)
L0 . However, through evo-
lution, the proliferative potential is redirected to-
ward C
(0)
L1 , i.e. [L1;z = 0], where cancer encoun-
ters only weakened immune reaction represented
by α
(0)
1 = αL.
These qualitative explanations reflect complexity
of the resistance-relevant processes and emphasize
importance of computational effort to better un-
derstand their role in immunotherapeutic proce-
dure. As a consequence, a single causal relation-
ship between effects and the respective specific fac-
tor is not sufficient for complete understanding, as
there is no single factor leading to the correspond-
ing effect. The results show that the selective phe-
notypic advantage is formed due to a combined
parametric effect comprising cellular response to
drug specificity, phenotypic commitment, environ-
mental dynamics, as well as other mechanisms in-
cluded in the model.
4 Discussion
In the paper, we have proposed a minimalist con-
cept of nonequilibrium modeling of the evolution
of phenotypic reversibility in time-varying envi-
ronments. The results demonstrate, at the method-
ological level, that the proposed ODE models can
be helpful in understanding of the characteristic
features of the evolutionary dynamics of genetic
and epigenetic phenotypic states. At some styl-
ized level, the space of alternatives is well de-
scribed by the presented quasispecies and popula-
tion models. As we have shown, a possible evolu-
tionary process can be better understood when the
structure of the underlying model involves com-
binations of low and high parametric values. In
particular, the former of the two studied models,
the quasispecies model, confirmed that under spe-
cific symmetric environmental conditions [where
according to Eq.(2.1) the replication rates of phe-
notypic states move in symmetrically opposite di-
rections dr(1)(t) = −dr(0)(t)] the clones with higher
reversibility may outcompete their less reversible
rivals, which is consistent with recent experimen-
tal findings [24]. Accordingly to both presented
models, the high degree of reversibility represents
an evolutionary advantage in the variable environ-
ments which disappears when the environments
become static and vice versa.
Modeling of environmental changes proposed in
this work is limited to stylized periodic variations.
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Further insights into the problem of variable envi-
ronments can be derived for the stochastic models
[72, 34, 73, 74, 52, 35, 36].
The model extension including more general
asymmetric environmental influence may be la-
borious, but straightforward. It seems that ecol-
ogy combining exogenous and endogenous envi-
ronmental influence (where asymmetry can be a
natural side product of the considerations) may be
more important at the present stage of the model-
ing. In our stylized model of cancer cell popula-
tion, the above abstract conceptualization is made
more instructive by defining a periodic environ-
ment where exogenous variability of the effector
cell population is considered.
Presented model of heterogeneous tumor growth
(Section 3) demonstrates the model-specific ther-
apeutic implications of evolved bet-hedging strat-
egy and phenotypic plasticity of cancer cells. The
levels of immunotherapeutic efficiency that cause
remarkable differences between genetic and epige-
netic entropy measures become prevalent at late
simulation times, where mutation changes become
very rare. Calculations show that effective thera-
pies can be expected in the (stable) parametric area
below a certain threshold of the parameter of ther-
apeutic specificity. In difference to, e.g. the model
[75], our model does not make a priori assumption
of underlying drug resistance. On the other hand,
the evolutionary viewpoint based on the concept of
heterogeneity is a natural source of algebraic com-
plications which presume more sophisticated the-
oretical treatment.
In general, many dynamic biosystems undergo a
fundamental change of behavior when one of their
parameters passes through a threshold value [76].
The concept of lethal threshold of unstable tu-
mor progression has been discussed in [44, 45].
The identification of the threshold as a non-linear
form of therapeutic effect on fitness is in line
with the work [72]. In [77], a model of tumor
growth is proposed where Allee threshold related
to the minimum density criterion plays a central
role. The ability to manipulate selectively the
(micro)environment with the sustainable intensity
and reliable detection of the threshold in the ther-
apeutic efficiency could be major challenges for
therapeutic applications, as exemplified may serve
immunotherapeutic intervention [78]. The con-
cept of environmental manipulation has been sup-
ported by experimental study [79] as well report-
ing that regular administration of drugs at non-
toxic doses may overcome the drug resistance by
shifting the therapeutic target from tumor cells to
tumor endothelial cells. This therapeutic strategy
is known under the term metronomic chemother-
apy and immunotherapy. Regarding this, we put
into attention one of the most findings from here
presented cancer model, which is a positive thera-
peutic effect achieved with less (see also [47]) when
moderate immunotherapeutic specificity (given by
xp) is assumed.
We note, that the original quasispecies model nat-
urally led to the concept of ”error threshold” for
selective competence (see e.g. Fig.2.3 and [80]).
Consequently, interesting question arises whether
the threshold concept is transferable to therapeutic
context as well.
Regarding the results of the threshold and sen-
sitivity analysis (see A.2), the interesting ques-
tion emerges whether carefully chosen linearized
model classes which retain the typical evolution-
ary properties can be constructed and used to an-
alyze the drug resistance observed in heteroge-
neous, evolving and variable cancer cell popula-
tions.
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A Appendices
A.1 Long run asymptotics - monoclonal
fixation
The quasispecies problem does not provide closed-
form expressions for the solution for a system
of many species. Nevertheless, numerical results
from Subsection 2.3 stimulated our interest in the
asymptotic situation t ≫ 1/µ where the limit cycle
oscillations can be identified. We also found that
for late-time evolution the single clone with the in-
dex ns/2 is fixed. The case of highly localized (in k)
species allows to consider more restrictive version
of the constraint Eq.(2.6) in the form
c(ns/2, t) = c
(0)(ns/2, t) + c
(1)(ns/2, t) = 1 . (A.1)
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Figure 4.1: Figure depicts results of the sensitivity analysis focused on the role of m, T , ∆r parameters.
The results were obtained for the time horizons th ∈ {1000,3000} [see panels (A),(C) with th = 1000; panels
(B),(D) with th = 3000] and constant µ = 0.01. Instead of particular dependencies on three parametric di-
mensions represented by m,T ,∆r (see Fig.2.3) (which lacks holistic perspective), we used ξ2(m,T ,∆r) (see
Eq.(A.8)) as a single independent variable. We have studied sensitivity on ξ2(m,T ,∆r) generated by the
(m,T ,∆r) combinations with bounds m ∈ 〈0.01,0.2〉, T ∈ 〈1,20〉, ∆r ∈ 〈0.1,0.4〉. Since 8 evenly spaced val-
ues have been used for each particular variable, 83 = 512 samples were drawn from the cubic hyper-lattice.
Subsequently, each particular (m,T ,∆r) vector was converted to the 2d projection consisting of the coordi-
nates [ξ2(m,T ,∆r),SEPIG(th−T ,th)], where SEPIG(th−T ,th)
def
= (1/T )
∑
t∈〈th−T ,th〉
SEPIG(t) [see panels (A), (B)].
Here, the summation is performed for the period T preceding th. In analogy with Fig.(2.3), the thresholds
reappear. When the plots (A), (B) are compared with the approximate form ln2 − ξ2 (see Eq.(A.11)), par-
ticular agreement can be found for sufficiently high ξ2 (low entropy) region where selection process for the
highest reversibility is more effective. The similar tendencies are exhibited by the mean replication mea-
sure r ef f ,max(th − T ,th)
def
= (1/T )
∑
t∈〈th−T ,th〉
maxk=0,...,ns−1 ref f (k, t) [see panels (C), (D), where ξc(m,T ,∆r)
defined by Eq.(A.7) plays a role analogous to that of ξ2; note that Eq.(2.15) is used to calculate ref f (k, t)]. The
long-time asymptotics rB +∆rξc is given by Eq.(A.10). In line with the expectations, the threshold is more
pronounced and the relation look sharper at larger th [panels(B), (D)].
It is consistent with two settings
c
(0)
Σ
(t) ≃ c(0)(ns/2, t) =
1
2
+ ξ(t) , (A.2)
c
(1)
Σ
(t) ≃ c(1)(ns/2, t) =
1
2
− ξ(t) ,
where the residual plasticity is transferred to the
single auxiliary −1/2 < ξ(t) < 1/2. Consequently,
using Eq.(2.3) we obtained Jsw(ns/2, t) = −ξ and the
equation for ξ(t) can be written as
dξ
dt
= (r0 −Φ)
(
1
2
+ ξ
)
−mξ . (A.3)
Substituting c(0)(t), c(1)(t) from Eq.(A.2) into
Eq.(2.15) we obtained
Φ(t) ≃ ref f (t) = rB +2∆r ξ(t)cos
(
2pit
T
)
. (A.4)
Its consequent substitution into Eq. (A.3) gives
dξ
dt
= 2∆r
(
1
4
− ξ2
)
cos
(
2pit
T
)
−mξ . (A.5)
This nonlinear ODE problem can be solved us-
ing the single harmonic approximation (valid for
ξ2 ≪ 1/4) of the limit cycle
ξ(t) ≃ ξs sin
(
2pit
T
)
+ ξc cos
(
2pit
T
)
(A.6)
with the pair of amplitudes
ξs =
piT∆r
4pi2 +T 2m2
, ξc =
mT
2pi
ξs . (A.7)
The formula clearly uncovers the relative effects
of the processes operating at different time scales:
1/∆r, 1/m and T . The dependence upon 1/µ ab-
sents due to assumption that clonal selection has
basically vanished in the long run.
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For the solutions given by Eq.(A.6), the time aver-
aging can be simply performed for the single pe-
riod. The result is
ξ2 ≃
1
2
(
ξ2s + ξ
2
c
)
. (A.8)
Similarly, for T -periodic ξ(t) the mean effective
replication rate can be defined by
ref f ≡
1
T
∫ T
0
ref f (t)dt . (A.9)
Then, using Eq.(2.15), Eq.(A.2), Eq.(A.4), Eq.(A.6)
and Eq.(A.9) we obtained
ref f = rB +∆r ξc . (A.10)
A posteriori confrontation with the condition
ξ2 ≪ 1/4 provides bounding ∆r ≪ (4pi2 +
T 2m2)/(piTmax{1,mT }). Based on the structure
of Eq.(A.10), we have proposed the numeri-
cal analysis illustrated by examples in Appendix
Fig.4.1(C),(D) (see caption of this figure for more
details). The combination with numerical tools in
part justifies the use of asymptotic approximation
presented in this Appendix.
We expect potential use of the result described by
Eq.(A.10) in increasing the efficiency of large-scale
modeling, performed for the time intervals that are
much longer than the period of the environment
contained in the replication rate. A similar type
of population-averaged growth rate is discussed in
[54] within the context of gene expression of bac-
terial populations exposed to environmental varia-
tions.
Assuming that the only clone (the winner) sur-
vives, we get a trivial limit SG |t→∞ → 0. However,
the epigenetic alterations have non-trivial conse-
quences. If Eq.(A.2) is substituted into Eq.(2.10),
one obtains
SEPIG(t) ≃ −
∑
j∈{−1,1}
(
1
2
+ jξ(t)
)
ln
(
1
2
+ jξ(t)
)
. (A.11)
The formula can be analyzed by calculating its
time averages. For this aim, the Taylor series of
the order O(ξ2) can be used. The entropy averaged
over the period SEPIG ≃ ln2 −ξ2 used in combina-
tion with Eq.(A.7) and Eq.(A.8) provides (SEPIG −
ln2) ∼ (−∆r2) in a qualitative agreement with the
simulation trend shown in Fig.2.2(A),(D),(E),(F),
Fig.2.3(B) and also short sensitivity study reported
in Appendix Fig.4.1(A),(B).
It is clear that the calculations of the characteristics
for separate variables are not universal across para-
metric values. The first step towards integrated
view is manifested in Fig.4.1, where the time av-
eraged SEPIG(t) and maxk ref f (k, t) are plotted ver-
sus auxiliary variables ξ2 and ξc [see Eq.(A.7)
and Eq.(A.8) below] for different combinations of
m,T ,∆r inputs. The explicit forms of ξ2(m,T ,∆r)
and ξc(m,T ,∆r) follow from the asymptotic re-
sults for the clone selection problem represented
by Eq.A.10.
Contrary to previous considerations let us abandon
for a moment predetermination of ϕ(kcentral). In-
stead, we discuss an alternative formulation that
assumes equivalence of the asymptotic evolution-
ary solution with the one-dimensional static maxi-
mum of the mean ref f (ϕ). Such analysis is suitable
for late times, when selection process is completed
and, consequently, k-dependency of ϕ(k) becomes
irrelevant. In that case, the parametrization as-
suming the real-valued ϕ ∈ 〈0,1〉 can be used and
subsequent optimization performed.
In analogy with Eq.(A.2) we assume c(z)(ϕ,t) =
1/2 + (−1)zξ˜(ϕ,t). Continuous ξ˜(ϕ,t) depen-
dence may serve for the selection of the ϕopt ∈
〈0,1〉 which solves the optimization task ϕopt =
argmaxϕ∈〈0,1〉 r˜ef f (ϕ). When ϕ remains unspeci-
fied, the original Eq.(A.5) may be rewritten to the
form
dξ˜
dt
=
∆r
2
(1− 4ξ˜2)cos
(
2pit
T
)
+m
(
1
2
− ξ˜ −ϕ
)
.(A.12)
In analogy with Eq.(A.4) we define r˜ef f (ϕ,t) = rB +
2∆rξ˜ cos(2pit/T ) and the corresponding time aver-
age r˜ef f (ϕ). Obviously, the conflict between dis-
crete ϕ(kcentral) and the solution of the continuous
problem, ϕopt , can occur if the list of the possible
discrete values {ϕ(k)}
ns−1
k=0 does not contain ϕopt .
Nowadays, stochastic model variants become rela-
tively independent field of research. For the lack of
space, below we outline only an elementary model
based on stochastic modification of the periodic
environmental model. The reasons are as it fol-
lows: (i) recent studies point to the extrinsic noise
as a factor influencing genetic and epigenetic deter-
minants of the replication; (ii) there is an increased
interest in a description of the intermediate envi-
ronments between strictly periodic and noise pro-
cesses; (iii) the noise responses can be considered
as a suitable stability indicators.
Our elementary stochastic extension is based on
the generalization in which the original regular
cos(2pit/T ) function from Eq.(A.12) is replaced by
the periodized variant wou (t) of the continuous
Ornstein-Uhlenbeck random continuous process
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described by
dwou =
1
τou
(
cos
(
2pit
T
)
−wou
)
+σoudW , (A.13)
where the constant σou changes the original unit
dispersion of the standard Wiener process W (t).
The basic idea of the process is that relaxation to
the instantaneous cos(2pit/T ) is described by the
relaxation time τou . Moreover, as the periodiza-
tion retains the influence of the former time scale
T , different levels of stochasticity can be simulated
using τou .
In accordance with the structure of Eq.(A.12), new
wou (t) term is used to modify
dξou
dt
=
∆r
2
(
1− 4ξ2ou
)
wou (t) (A.14)
+ m
(
1
2
− ξou −ϕ
)
as well as the effective replication rate rou−ef f =
rB + 2∆rξouwou . Again, to determine the optimum
uniquely, the quantity rou−ef f (ϕ) needs to be inves-
tigated for the late times where the effects of initial
conditions become negligible.
As depicted in Fig.A.1), the solution of the initial
value problem obtained for given ϕ can be used
to calculate rou−ef f (ϕ). Since we are focussed on
the region of τou ≪ T and very small σou , there
is no need for separate presentation related to de-
terministic limit. Two claims could be made re-
garding wou , ξou and rou−ef f properties: (a) Be-
cause the relaxing of wou (t) is unable to reach
the heights of harmonic amplitudes, the process
ξou (t) causes that rou−ef f (ϕ) values are systemati-
cally smaller than their deterministic counterparts;
(b) The fluctuations characterized by the variance
Var(rou−ef f (ϕ,t) − rB) show an extremal impact of
the highly unstable boundary regions ϕ → 0+ and
ϕ→ 1−.
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Figure A.1: The effective replication rate and corresponding fluctuations calculated for the parameters T =
10, ∆r = 0.1, m = 0.1 using Eq.(A.14). To attain stationary regime, initial 200 periods were discarded. Next
thousand periods were used to calculate the mean values. Panel A confirms the optimality of the mean
clonal replication for ϕ = 1/2 is confirmed. According to panel (B), the largest fluctuations are observed for
the boundary region.
A.2 Therapeutic threshold, initial
stages of tumor formation, sen-
sitivity analysis
To conceive better the effect of the therapeutic
threshold as well as to support generality of the
suggested concept (for xp parameter), we analyze
initial stages of the tumor formation inmore detail.
Additionally to our previous layout, below we fo-
cus on the sensitivity analysis in the space of ther-
apeutic options or available uncertain inputs. For
that aim, we formulate the threshold problem in a
way enabling us to carry out suitable analytical or
semi-analytical approximations.
Although the issues of uncertainty and risk are
not typically addressed within the ODE, the rele-
vant information in this context can be obtained by
studying assembly of alternative phase shifts that
are exogenous inputs of our ODE system. Assum-
ing that medical treatment will be confronted with
an uncertainty in the abundance of the effector cell
population (∼ ∆e), the additional phase variabil-
ity has been incorporated by modifying the origi-
nal periodic model of e(t). In the modified version,
for every simulation run j = 1,2, . . . ,Ne of the dura-
tion th the specific j-dependent phase shift 2pij/Ne
is introduced as an extra degree of freedom with
the corresponding abundance
ej (t) = eB +∆e cos
[
2pi
(
j
Ne
+
t
T
)]
(A.15)
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Figure A.2: Auxiliary calculations that allow us to better understand the complexities around the threshold
of the parameter xp. Calculations, as in many previous cases, were performed for parameters a = 1, r = 1,
m = 0.05, µ = 0.01, T = 10, g = 0.45, eB = 0.5, ∆e = 0.4, ϕL = 0.25, CP0 = 0.001. The new parameter
δCP0 = 0.0001 [see Eq.(A.17)] characterizes initial separation of trajectories; Ne = 20 variants of the phase
shifted ej (t) and ej (0) have been taken into account to characterize the sensitivity. Panels (A), (B) show how
the growth instability is manifested by the Lyapunov-like exponents ΛΣ,j , j = 1,2, . . . ,Ne. We see that the
influence of phase shifts is getting weaker as the time is passing [shadowing of initial condition Eq.(3.12)
where the sole nonzero abundance isCP (0)]. For the purposes of alternative approach, we consider panels (C)
and (D) including det(Q(ej(0))) (as a product of eigenvalues) and det(Q˜L1(ej (0))), respectively. Interestingly,
there are many mutual crossings in (D) starting above xp ∼ 1.2. Panel (E) shows maximal and minimal
elements of the set ΛReQ (ej (0)) (determined for each ej (0) separately). Alternatively, the system of dispersions
in panel (F) helps us to characterize the distribution of eigenvalues arranged in ΛReQ (ej (0)).
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on the interval t ∈ 〈0, th〉. In such case, dynamics of
ej (t) influences the respective population dynam-
ics through ∝ −α˜aej (t)C˜/(CΣ,j + g) term modifying
the original form of Eq.(3.6). The sensitivity to the
phase differences provide additional information
related to the system trajectories.
We assume that within the context of here studied
growth phenomena, the relevant information can
be described by the Lyapunov-like exponent
ΛΣ,j =
1
th
ln
∣∣∣∣C[1]Σ,j (th)−C[2]Σ,j (th)∣∣∣∣
|δCP0|
. (A.16)
defined by means of two horizon values C
[1]
Σ,j (th),
C
[2]
Σ,j (th) [splitting the original CΣ from Eq.(3.4)] ob-
tained under the action of ej(t) for two initial con-
ditions
path C
[1]
Σ,j (t) : initial CP(0) = CP0 , (A.17)
path C
[2]
Σ,j (t) : initial CP(0) = CP0 + δCP0 ,
where δCP0 is small shift in CP0 defined by
Eq.(3.12).
Since the system of phenotypes begins to evolve
from a small monoclonal primary tumor, there is
no initial heterogeneity (see Fig.2.2 and Fig.3.2).
Thus, for small times the dynamics of species
abundances allows for a linear analysis that of-
fers some computational benefits. This section
continues with the development of semi-analytical
approximation which supports relevance of the
threshold approach. The aim is to extend this in-
tuitive concept by examining stability of the initial
conditions quantified by the spectrum of the local
Lyapunov exponents.
Within the applied quasi-static approximation
each ej (t), j = 1,2, . . . ,Ne is replaced by the constant
value ej (0) = eB +∆e cos(2pij/Ne). In such elemen-
tary case, Eq.(3.9) can be linearized in the vicinity
of the initial condition given by Eq.(3.12). The lin-
earization provides an approximate solution with
the dynamic ”fastest” mode written in the matrix
form exp(Q(ej (0))t), where Q(ej (0)) denotes the lo-
cal Jacobian matrix of the system Eq.(3.9) we spec-
ify in the following. Then, the diagonalization of
Q(ej (0)) can be performed and the stability of the
initial condition can be checked by investigating
real parts of eigenvalues
Λ
Re
Q,j ≡ℜ[diag(Q(ej (0))] (A.18)
Then, by studying Ne variants of Λ
Re
Q,j spectra the
possible impacts of the therapy on the very early
stages of tumor formation can be obtained.
For later purposes, we introduce auxiliary vari-
ables
rP0 = r(1−CP0) , ae =
aej (0)g
(CP0 + g)2
, (A.19)
QP = rP0 − rCP0 − ae − 6µ,
Qae = (ae − r)CP0 .
The resulting Q can be ordered into the blocks
Q =

QP (Qae , Qae) (Qae , Qae) (Qae , Qae)(µ
µ
)
Q˜L0 02×2 02×2
(µ
µ
)
02×2 Q˜L1 02×2
(µ
µ
)
02×2 02×2 Q˜H

.(A.20)
Here, the evolutionary mechanism is highlighted
by the leftmost column which mediates the inter-
connection of species. The first row including non-
diagonal Qae elements simply reflects the immune
feedback. Three 2× 2 sub-matrices of the type
Q˜X =
 Q(0)X m(1−ϕL)
mϕL Q
(1)
X
 , X ∈ {L0,L1,H} (A.21)
correspond to the respective clones L0,L1,H . Their
switching capability is evident from the nondiago-
nal structure of Q˜X . The interplay of the prolif-
erative, switching, immune and therapeutic effects
is compactly expressed in the following diagonal
terms Q
(z)
X , z ∈ {0,1}. For the phenotypic alterna-
tive z = 0 we have
Q
(0)
L0
Q
(0)
L1
Q
(0)
H
 = rP0 −m

ϕL
ϕL
1
2
−
aej (0)
CP0 + g

xp
1
xp
xp
 , (A.22)
whereas in the z = 1 case we obtained
Q
(1)
L0
Q
(1)
L1
Q
(1)
H
 = rP0 −m

1−ϕL
1−ϕL
1
2
−
aej (0)
CP0 + g

1
xp
xp
1
xp
 . (A.23)
The methodology offers interpretation in which
the threshold of xp separates the phase of small
and large instability. The results of numerical cal-
culations are shown in Fig.A.2. Important gen-
eral finding is, that the threshold behavior can
be manifested not only by the nonlocal measures
(e.g. using ΛΣ,j ), but by the calculations based on
Q(ej (0)) as well. The long-term (th = 100T ) depen-
dence ΛΣ,j (xp) depicted in Fig.A.2(B) seems to be
fairly consistent with roughly estimated threshold
xp,thr ∈ (1.12, 1.14) identifiable from Fig.3.1(H). In
addition, regarding sensitivity to ej (t), Fig.A.2(B)
shows that after a long period, the consequences
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of the phase differences gradually vanish due to
convergence onto the universal (in the sense of its
phase-independence) limit cycle attractor. Con-
versely, the panel (A), where th = 10T , shows no
more evidence for the threshold-type behavior in
the terms ΛΣ,j . Regarding evaluation of the set of
the measures derived from Q(ej (0)), it seems that
detailed enough knowledge available from the lo-
cal characteristics derived from Q(ej (0)) makes it
possible to substitute the lack of information.
The local characteristics based on Q(ej (0)) show
capacity to unmask expanding or contracting ten-
dencies that vary with xp . While det(Q(ej (0))) de-
picted in the panels (C), (D) indicates that system
of trajectories may begin to expand due to xp , the
minors det(QL1(ej (0))), j = 1,2, . . . ,Ne, on the con-
trary, indicate a shift towards more contractive ef-
fects (we verified that minors det(Q˜L0) and det(Q˜H )
confirm the same tendency). It means, that thera-
peutically induced separation of eigenvalues ΛReQ,j
[see panels (E), (F) of Fig.A.2 ] cannot be simply at-
tributed to diversity of subpopulations, but, more
likely, it reflects diversity of the replication rates
causing the rapid clonal expansion with possible
dominance of fittest species.
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